A new approach for moving promising discoveries out of laboratories and into the hands of patients and physicians
With the “Valley of Death” looming as an increasingly serious obstacle to introducing better ways of preventing, diagnosing and treating diseases, a noted scientist today described a new approach for moving promising discoveries out of laboratories and into the hands of patients and physicians. He spoke at the 246th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society, being held here this week.
Dennis Liotta, Ph.D., cited widespread concern that innovative scientific discoveries, especially those resulting from billions of dollars in government investment in research, are withering on the vine rather than being translated into breakthrough new treatments.
“The Valley of Death is the place where potential new drugs all too often go to die,” said Liotta. “In drug development parlance, the Valley of Death refers to the obstacles that are keeping innovative medical research discoveries from becoming new drugs. Potential new drugs never even make it to clinical trials. We think we have an approach to bridge the valley.”
Liotta has been involved in moving 10 drugs into the hands of patients as medications approved by the U.S. Food and Drug Administration. Among them is the HIV drug Emtriva®, which was co-invented by Liotta, Raymond Schinazi and Woo-Baeg Choi and approved by the U.S. Food and Drug Administration in 2003. Emtriva® is now used in more than 90 percent of all HIV combination therapies prescribed around the world. In 2005, Emory University, where the drug was developed, sold its royalty interest in Emtriva® for $540 million to Gilead Sciences Inc.
The chances of a promising new discovery actually becoming a new drug always have been razor-slim, Liotta said. Hundreds of such discoveries happen each year, but only a handful of truly new medicines reach the market. Others are “me-too” drugs, similar to drugs approved in the past but in forms that have longer-lasting effects or with other minor improvements. But circumstances are making the Valley of Death even more hazardous, further reducing the movement of new compounds from lab to real-world remedies.
“Big pharmaceutical companies are cutting back on the kind of research and development activity needed to introduce truly new drugs,” Liotta said. “Research universities are the logical institutions to step in and complement the work in private industry. Dozens of universities have such programs, but with a focus that makes it difficult for them to move a potential new drug forward to the point of clinical trials.”
To fill that gap, Emory used $30 million from the royalty sale of Emtriva® to form two nonprofits: Drug Innovation Ventures at Emory (DRIVE) and the Emory Institute for Drug Development (EIDD). DRIVE’s goal is to invest in discoveries with the potential to become new drugs. In effect, DRIVE is the “industrial partner” of the EIDD, organized as a virtual drug development company with a highly experienced management team. As a nonprofit, DRIVE can license attractive development opportunities from Emory or elsewhere on commercially favorable terms.
“With either its own seed capital or external funds, DRIVE then can use EIDD or external vendors to move these opportunities quickly and efficiently down the development continuum to meet the critical need for new therapeutic agents to treat infectious diseases,” Liotta said.
The Latest Bing News on:
Drug development
- How AI Could Transform Drug Development And The Life Scienceson May 2, 2024 at 11:45 am
The implementation of AI in healthcare spans from developing drugs to using AI in the real world. This panel from Imagination In Action's 'Forging the Future of Business with AI' Summit talks about ...
- Deeper understanding of malaria parasite sexual development unlocks opportunities to block disease spreadon May 2, 2024 at 11:00 am
For the first time, the developmental stages of the deadliest human malaria parasite have been mapped in high resolution, allowing researchers to understand this ever-adapting adversary in more detail ...
- Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Teamon May 2, 2024 at 10:00 am
He brings valuable leadership to our world-class DDC team, a full-service global drug development and strategic regulatory team providing comprehensive "inception to approval" services.” The DDC ...
- BridgeBio spinout launches with $200M for KRAS cancer drugson May 2, 2024 at 4:16 am
The company, BridgeBio Oncology Therapeutics, has one drug in the clinic and hopes to soon advance two other candidates.
- Project Optimus: helping or hindering cancer drug development?on May 2, 2024 at 1:01 am
Experts say that Project Optimus is a necessary reform in the oncology space, but one that should be applied with caution.
- High blood pressure drug called 'rilmenidine' dramatically slows aging in animalson May 1, 2024 at 2:41 pm
A drug used for high blood pressure, known as rilmenidine, may also be effective in slowing the aging process.
- Potential Effects of the Inflation Reduction Act on Orphan Drug Developmenton April 30, 2024 at 5:00 pm
In order to promote the development of orphan drugs, Congress passed the Orphan Drug Act in 1983. This statute created incentives for manufacturers to discover, sponsor and market drugs for rare ...
- Harmony Biosciences shares soar on acquisition of New Jersey epilepsy drug developeron April 30, 2024 at 8:31 am
The deal consists of an upfront payment of $35 million and potential milestone payments of up to $645 million.
- Xaira Launches with $1 Billion to Pioneer AI-Driven Drug Discoveryon April 28, 2024 at 11:36 pm
Xaira Therapeutics, an AI drug discovery startup, recently launched with a remarkable $1 billion funding, backed by prominent investors like ARCH Venture Partners and Foresite Labs. The company, led ...
- A Pharmaceutical Company is Working to Speed Up the Drug Development Process with AIon April 28, 2024 at 9:50 pm
Algorae Pharmaceuticals is finding ways to revamp its process of drug development from cost saving and speed to timeline of drug research and delivery by ...
The Latest Google Headlines on:
Drug development
[google_news title=”” keyword=”Drug development” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
New drug discovery
- Drug Discovery Informatics Market Growth 2024: Anticipated To Reach USD 7.9 Billion By 2032on May 1, 2024 at 5:00 pm
The Drug Discovery Informatics Market is expected to grow with a significant CAGR during the analysis period mainly due to rise in chronic diseases and the advent of new powerful tools such as AI and ...
- Johann Hari's compelling but flawed look at the new weight-loss drugson May 1, 2024 at 10:00 am
Drugs like Ozempic may help fight obesity. Johann Hari’s first-person account of taking the new medicines is a fascinating exploration of their impact ...
- Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testson May 1, 2024 at 6:47 am
"Drug discovery and development is the ultimate scientific team sport," he said. "Aculeus has developed a promising new drug but the collaboration with the WEHI teams, that have a deep understanding ...
- Bloodsucking fly behind ‘new drug discovery’on May 1, 2024 at 12:11 am
Researchers at the University of Sydney have discovered a potentially “game-changing” new drug capable of preventing blood clots and fatal bleeding during surgery – thanks to the bloodsucking African ...
- NYC-based AI drug discovery company moves HQ to Cambridgeon April 30, 2024 at 6:57 am
If you are not in Boston, you are not in biotech, in my opinion,” said the founder of Insilico, a 10-year-old AI drug discovery company that's moving its headquarters from New York to Massachusetts.
- AI-Driven Drug Discovery by Pfizer and Austrian Institute Set to Transform Healthcareon April 26, 2024 at 5:38 am
Pfizer, the top pharmaceutical firm, and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) have developed an AI-driven drug discovery method The novel approach, ...
- This Biotech Startup Aims To Speed Up Drug Testing On Animalson April 26, 2024 at 3:29 am
Gordian Biotechnology’s platform allows for potentially hundreds of gene therapies to be tested in an animal at the same time — without harming it.
- Using Explainable AI To Ensure Drug Discovery Safetyon April 25, 2024 at 5:00 pm
but the company claims to have found a new drug 10 times faster – it’s not a fair comparison. I think that clinical translation will become the next big focus area. Are these AI drug discovery ...
- The Difference Is the Data: Drug Discovery’s AI Revolutionon April 25, 2024 at 4:00 am
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
- New AI drug discovery powerhouse Xaira rises with $1B in fundingon April 24, 2024 at 3:00 am
If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you, it couldn’t dream up one like Xaira Therapeutics. | If you asked an AI to ...
The Latest Google Headlines on:
New drug discovery
[google_news title=”” keyword=”new drug discovery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]